20 May 2003 : Original article
Comparative efficacy of interferon therapy (IFT)in patients with chronic hepatitis C (CHC)depending on histological grade and stage
N. Matievskaya, N. Prokopchik, V. TsyrkunovMed Sci Monit 2003; 9(2): 11-12 :: ID: 15257
Abstract
Background:To compare the efficacy of IFT in patients depending on the histological activity degree and disease stage.Material/Methods: The results of IFT have been analysed in 50 patients with CHC.There are 40 males and 10 females in the studied group.Mean age of patients was 36.6 ±16.6.All the patients underwent liver biopsy before IFT and in 6 months after its accomplishment.The histological examination has been made according to Knodell scoring system.31 patients had CHC of mild activity (a necroinflammatory score was in range 1 –8),19 patients –of moderate activity (a necroinflammatory score was in range 9 –12).Fibrosis score of 0 was in 10 patients, fibrosis score of 1 –in 24 patients,fibrosis score of 3 –in 15 patients.All the patients were receiving monotherapy with a -2 b Interferon preparations within 6 months.The groups were compared according to biochemical response rate (BR),namely,reduction of ALT activity on the background of IFT,virological response (VR)–disappearance of RNA HCV after IFT course,morphological response (MR)–reduction of inflammation and fibrosis degree in the control biopsy.Results:The rate of BR did not differ significantly in patients with hepatitis of mild activity in comparison with ones who had hepatitis of moderate activity (25/31 v.6/19,respectively, p>0.05).VR was in 10/31 patients with hepatitis of mild activity v.4/19 patients with hepatitis of moderate activity (p>0.05),MR was in 30/31 patients with hepatitis of mild activity and in 6/19 patients with hepatitis of moderate activity (p>0.05).BR was found out evidently more frequently in patients with fibrosis 0 in comparison with the patients who had fibrosis 3 (9/10 patients v.6/15,respectively p0.3).VR was significantly more frequent in patients with fibrosis 0 as compared with the patients having fibrosis 1 and fibrosis 3(7/10 v.4/24,p0.05).Conclusions:1.Patients with chronic hepatitis C and progressive fibrosis stage had significantly low rate of BR and VR on IFT in comparison with ones who did not have fibrosis in liver biopsy,it should be taken into consideration while admi- nistering IFT.2.Histological activity degree did not influence on the efficacy of IFT in the studied group.
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952